Aktaş, Nimet2023-11-092023-11-092018Oruç, A. vd. (2018). ''Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome''. Nefrologia, 38(4), 448-450.0211-69951989-2284https://doi.org/10.1016/j.nefroe.2018.04.004https://www.sciencedirect.com/science/article/pii/S2013251418300622http://hdl.handle.net/11452/34810eninfo:eu-repo/semantics/openAccessUrology & nephrologyComplement inhibitor eculizumabAdultAntibodies, monoclonal, humanizedAtypical hemolytic uremic syndromeChemical and drug induced liver injuryHumansMaleHepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndromeHepatotoxicidad asociada con eculizumab en un paciente con síndrome urémico hemolítico atípicoLetter0004390997000192-s2.0-8504999452644845038429221881Urology & nephrologyAminotransferaseAmlodipineCarvedilolCreatinineEculizumabLactate dehydrogenaseMethyldopaRamiprilEculizumabMonoclonal antibodyAdultBlood pressure regulationBlood smearCase reportClinical articleCreatinine blood levelDisease classificationDrug withdrawalEchographyFatty liverHeadacheHemolytic uremic syndromeHepatomegalyHumanHuman cellHuman tissueHypertension retinopathyKidney biopsyLaboratory testLactate dehydrogenase blood levelLetterLiver toxicityMalePhysical examinationPlasma exchangeThrombocytopeniaThrombotic thrombocytopenic purpuraTreatment durationComplicationHemolytic uremic syndromeToxic hepatitis